Therapeutically Targeted Anticancer Agents: Inhibitors of Receptor Tyrosine Kinases
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
4
Page:
273-283
Author(s):
Carlos Garcia-Echeverria and Doriano Fabbro
Pharmacogenetics of the Human MDR1 Multidrug Transporter
Journal:
Current Pharmacogenomics
Volume:
2
Page:
1-11
Author(s):
Caroline G. Lee, Samuel S. Chong and Edmund J. D.Lee
Therapeutic Options in Prevention and Treatment of Aspartoacylase Gene Mutation Resulting Abnormalities in Canavan Disease
Journal:
Current Pharmacogenomics
Volume:
2
Page:
13-20
Author(s):
Sankar Surendran, Stephen K. Tyring, Kimberlee Michals-Matalon and Reuben Matalon
Carotenoids and Modulation of Cancer: Molecular Targets
Journal:
Current Pharmacogenomics
Volume:
2
Page:
35-45
Author(s):
Paola Palozza
Biology of Protooncogene c-kit Receptor and Spermatogenesis
Journal:
Current Pharmacogenomics
Volume:
2
Page:
47-60
Author(s):
Supriya Gangadharan Prasanth, Harleen Mangat Giran and Sher Ali
Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)
Journal:
Current Pharmacogenomics
Volume:
2
Page:
75-82
Author(s):
R. M. Phillips and S. Basu
Subject Index to Volume 1
Journal:
Current Pharmacogenomics
Volume:
2
Page:
115-117
Author(s):
Bentham Science Publishers
Current Understanding of In-stent Restenosis and the Potential Benefit of Drug Eluting Stents
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
4
Page:
103-117
Author(s):
M. Froeschl, S. Olsen, X. Ma and E. R. O'Brien
Subject Index to Volume 3
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
4
Page:
121-123
Author(s):
Bentham Science Publishers
Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
71-81
Author(s):
Joseph Ciccolini, Alexandre Evrard and Pierre Cuq